Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis

Molecular Cancer Research

Volumn 2, Issue 10, 2004, Pages 557-566

  Enns, Louise ^a   Bogen, Kenneth T ^b   Wizniak, Juanita ^a   Murtha, Albert D ^a   Weinfeld, Michael ^a  

^a CROSS CANCER INSTITUTE   (Canada)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PIFITHRIN; PROTEIN INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; ENZYME ASSAY; GAMMA IRRADIATION; GAMMA RADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LOW ENERGY RADIATION; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; SKIN FIBROBLAST;

ADENOCARCINOMA; APOPTOSIS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; FIBROBLASTS; GLIOMA; HUMANS; LUNG NEOPLASMS; RADIATION DOSAGE; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 6344235257     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Upton AC. Carcinogenic effects of low-level ionizing radiation: problems and prospects. In Vivo 2002;16:527-33.
2. Murtha AD. Review of low-dose-rate radiobiology for clinicians. Semin Radiat Oncol 2000;10:133-8.
3. Marples B, Joiner MC. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat Res 1993;153:41-51.
4. Joiner MC, Lambin P, Malaise EP, et al. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res 1996;358:171-83.
5. Wouters BG, Skarsgard LD. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity. Radiat Res 1994;138:S76-80.
6. Wouters BG, Sy AM, Skarsgard LD. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different sensitivity. Radiat Res 1996;146:399-413.
7. Wouters BG, Skarsgard LD. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells. Radiat Res 1997;148:435-42.
8. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001;49:379-89.
9. 2-phase cells. Radiat Res 2004;161:247-55.
10. 2-phase cell radiosensitivity? Cancer Metastasis Rev 2004;23:197-207.
11. Marples B, Joiner MC. Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased radioresistance. Int J Radiat Biol 2000;76:305-12.
12. Short SC, Woodcock M, Marples B, Joiner MC. Effects of cell cycle phase on low-dose hyper-radiosensitivity. Int J Radiat Biol 2003;79:99-105.
13. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 2002;22:1049-59.
14. Chandra S, Dwarakanath BS, Khaitan D, Mathew TL, Jain V. Low-dose radiation hypersensitivity in human tumor cell lines: effects of cell-cell contact and nutritional deprivation. Radiat Res 2002;157:516-25.
15. Short SC, Mitchell SA, Boulton P, Woodcock M, Joiner MC. The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol 1999;75:1341-8.
16. Weaver JC, Bliss JG, Harrison GI, Powell KT, Williams GB. Microdrop technology: a general method for separating cells by function and composition. Methods Enzymol 1991;2:234-47.
17. Goguen B, Kedersha N. Clonogenic cytotoxicity testing by microdrop encapsulation. Nature 1993;363:189-90.
18. Bogen KT, Enns L, Hall LC, et al. Gel microdrop flow cytometry assay for low-dose studies of chemical and radiation cytotoxicity. Toxicology 2001;160:5-10.
19. Short S, Mayes C, Woodcock M, Johns H, Joiner MC. Low dose hypersensitivity in the T98G human glioblastoma cell line. Int J Radiat Biol 1999;75:847-55.
20. Jaenicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998;273:9357-60.
21. 2-M arrest in human cells. Mol Cell Biol 2000;20:2358-66.
22. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996;10:587-97.
23. van Engeland M, Ramekers FCS, Schutte B, Reutelingsperger CPM. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996;24:131-9.
24. Smyth PG, Berman SA, Bursztajn S. Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 2002;32:648-65.
25. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
26. Komarov PG, Komorova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-7.
27. 2 arrest after DNA damage. Science 1998;282:1497-501.
28. Singh B, Arrand JE, Joiner MC. Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int J Radiat Biol 1994;65:457-64.
29. Barley RDC, Enns L, Paterson MC, Mirzayans R. Aberrant p21(WAF1)-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations. Oncogene 1998;17:533-41.
30. Mothersill C, Kadhim MA, O'Reilly S, et al. Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line. Int J Radiat Biol 2000;76:799-806.
31. Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys 1990;18:1261-9.
32. Mitchell CR, Folkard M, Joiner MC. Effects of exposure to low-dose-rate 60 Co γ rays on human tumor cells in vitro. Radiat Res 2002;158:311-8.
33. Hendrikse AS, Hunter AJ, Keraan M, Blekkenhorst GH. Effects of low dose irradiation on TK6 and U937 cells: induction of p53 and its role in cell-cycle delay and the adaptive response. Int J Radiat Biol 2000;76:11-21.
34. Yu Y, Little JB. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res 1998;58:4277-81.
35. Lu W, Lin J, Chen J. Expression of p14ARF overcomes tumor resistance to p53. Cancer Res 2002;62:1305-10.
36. Ullrich SJ, Sakaguchi K, Lees-Miller SP, et al. Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A 1993;90:5954-8.
37. Weller M, Winter S, Schmidt C, et al. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone. Int J Cancer 1997;73:707-14.
38. Selvin S. Practical biostatistical methods. Belmont (CA): Duxbury Press; 1995.
39. Wolfram S. The Mathematica book. 4th ed. Cambridge (United Kingdom): Cambridge University Press; 1999.
40. Palcic B, Jaggi B. Bioinstrumentation: research, developments and applications. In: Wise DL, editor. Stoneham (MA): Butterworth; 1990. p. 923-91.
41. Belloc F, Belaud-Rotureau MA, Lavignolle V, et al. Flow cytometry detection of caspase-3 activation in preapoptotic leukemic cells. Cytometry 2000;40:151-60.